Management of tumor overgrowth in esophageal cancer by placement of a second stent: two case reports

Autor: Jc, Ribeiro, Df, Gomes, Hm, Lopes, Paulo Souto, Silva Pontes Jm, Oliveira E., Hj, Gouveia, Mj, Leitão, Freitas Dda S

Publikováno v: Europe PubMed Central

We present two cases of tumor overgrowth after stenting in patients with inoperable esophageal cancers that were managed by placement of a second tube. The macroscopic pattern of the tumor overgrowth was infiltrative, contraindicating it for laser th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dc3a549bf45cfd4242818d18080068e7
https://pubmed.ncbi.nlm.nih.gov/8975962

Confirmation of the shell-boring oyster parasite Polydora websteri (Polychaeta: Spionidae) in Washington State, USA.

Autor: Martinelli JC; School of Aquatic and Fishery Sciences, University of Washington, Seattle, WA, 98105, USA. julimar@uw.edu., Lopes HM; School of Aquatic and Fishery Sciences, University of Washington, Seattle, WA, 98105, USA., Hauser L; School of Aquatic and Fishery Sciences, University of Washington, Seattle, WA, 98105, USA., Jimenez-Hidalgo I; School of Aquatic and Fishery Sciences, University of Washington, Seattle, WA, 98105, USA., King TL; Washington Sea Grant, University of Washington, Shelton, WA, 98584, USA., Padilla-Gamiño JL; School of Aquatic and Fishery Sciences, University of Washington, Seattle, WA, 98105, USA., Rawson P; School of Marine Sciences, University of Maine, Orono, ME, 04469, USA., Spencer LH; School of Aquatic and Fishery Sciences, University of Washington, Seattle, WA, 98105, USA., Williams JD; Department of Biology, Hofstra University, Hempstead, NY, 11549, USA., Wood CL; School of Aquatic and Fishery Sciences, University of Washington, Seattle, WA, 98105, USA.

Publikováno v: Scientific reports [Sci Rep] 2020 Mar 03; Vol. 10 (1), pp. 3961. Date of Electronic Publication: 2020 Mar 03.

Ensuring head and neck oncology patients receive recommended pretreatment dental evaluations.

Autor: Margalit DN; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY dmargalit@lroc.harvard.edu., Losi SM; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY., Tishler RB; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY., Schoenfeld JD; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY., Ann Fugazzotto J; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY., Stephens J; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY., Cebulski AL; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY., Hammerstrand EL; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY., Ma L; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY., Lopes HM; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY., Haddad RI; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY., Treister NS; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY., Frustino JL; Brigham and Women's Hospital; Dana-Farber Cancer Institute; Center for Clinical Excellence, Brigham and Women's Hospital, Boston, MA; and Center for Oncology Care at Erie County Medical Center, Buffalo, NY.

Publikováno v: Journal of oncology practice [J Oncol Pract] 2015 Mar; Vol. 11 (2), pp. 151-4. Date of Electronic Publication: 2015 Jan 27.

Improved synthesis of seven aromatic Baylis-Hillman adducts (BHA): evaluation against Artemia salina Leach. and Leishmania chagasi.

Autor: Barbosa TP; Departamento de Química, Universidade Federal da Paraíba, Campus I, 58059-900 João Pessoa, PB, Brazil., Junior CG, Silva FP, Lopes HM, Figueiredo LR, Sousa SC, Batista GN, da Silva TG, Silva TM, de Oliveira MR, Vasconcellos ML

Publikováno v: European journal of medicinal chemistry [Eur J Med Chem] 2009 Apr; Vol. 44 (4), pp. 1726-30. Date of Electronic Publication: 2008 Mar 29.

Treatment of benign hepatic cysts by instillation of tetracycline hydrochloride.

Autor: Lopes HM; Department of Gastroenterology, Coimbra University Hospital, Portugal., Portela FA, e Silva Pontes JM, Leitão MJ, Ribeiro JC, Freitas DS

Publikováno v: Hepato-gastroenterology [Hepatogastroenterology] 1998 Mar-Apr; Vol. 45 (20), pp. 496-9.